Suppr超能文献

涉及AMPK和CLYBL乙酰化的正反馈回路将代谢重塑与炎症反应联系起来。

Positive feedback loop involving AMPK and CLYBL acetylation links metabolic rewiring and inflammatory responses.

作者信息

Wang Wenke, Wu Boquan, Hao Mingjun, Chen Sichong, Cong Ruiting, Wu Wenjie, Wang Pengbo, Zhang Qiaoyi, Jia Pengyu, Song Yuequn, Liu Bo, Qu Siyao, Pei Jian-Fei, Li Da, Zhang Naijin

机构信息

Center of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, 110004, China.

NHC Key Laboratory of Advanced Reproductive Medicine and Fertility (China Medical University), National Health Commission, Shenyang, 110004, China.

出版信息

Cell Death Dis. 2025 Jan 25;16(1):41. doi: 10.1038/s41419-025-07362-0.

Abstract

Metabolic rewiring underlies effective macrophages defense to respond disease microenvironment. However, the underlying mechanisms driving metabolic rewiring to enhance macrophage effector functions remain unclear. Here, we demonstrated that the metabolic reprogramming in inflammatory macrophages depended on the acetylation of CLYBL, a citramalyl-CoA lyase, at lysine 154 (K154), and blocking CLYBL-K154 acetylation restricted the release of pro-inflammatory factors. Mechanistically, we found a crucial AMPK-CLYBL acetylation positive feedback loop, triggered by toll-like receptors (TLRs), involving AMPK hypophosphorylation and CLYBL hyperacetylation. The deacetylase enzyme SIRT2 acted as the bridge between AMPK phosphorylation and CLYBL acetylation, thereby regulating macrophage polarization and the release of pro-inflammatory cytokines. Furthermore, CLYBL hypoacetylation decreased monocyte infiltration, thereby alleviating cardiac remodeling. These findings suggest that the AMPK-CLYBL acetylation positive feedback loop serves as a metabolic switch driving inflammatory response and inhibiting CLYBL-K154 acetylation may offer a promising therapeutic strategy for inflammatory response-related disorders.

摘要

代谢重编程是巨噬细胞有效抵御疾病微环境的基础。然而,驱动代谢重编程以增强巨噬细胞效应功能的潜在机制仍不清楚。在此,我们证明炎症巨噬细胞中的代谢重编程依赖于柠檬酸苹果酰辅酶A裂解酶(CLYBL)赖氨酸154(K154)位点的乙酰化,阻断CLYBL-K154乙酰化会限制促炎因子的释放。从机制上讲,我们发现了一个由Toll样受体(TLR)触发的关键的AMPK-CLYBL乙酰化正反馈环,涉及AMPK去磷酸化和CLYBL高乙酰化。去乙酰化酶SIRT2作为AMPK磷酸化和CLYBL乙酰化之间的桥梁,从而调节巨噬细胞极化和促炎细胞因子的释放。此外,CLYBL低乙酰化减少单核细胞浸润,从而减轻心脏重塑。这些发现表明,AMPK-CLYBL乙酰化正反馈环作为驱动炎症反应的代谢开关,抑制CLYBL-K154乙酰化可能为炎症反应相关疾病提供一种有前景的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbcc/11762313/4e2fd9f70ec0/41419_2025_7362_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验